AKT1 and pancreatic neoplasm: Notably, silencing of Akt or mTOR using gene-specific siRNA enhanced the sensitivity of pancreatic cancer cells to bardoxolone methyl, indicating that these pathways are critical targets for its antiproliferative and pro-apoptotic activity [92].